Giovannoni G, Rammohan K, Cook S, et al. Proportions of patients with highly active RMS achieving no evidence of disease activity (NEDA) in response to cladribine tablets in CLARITY. ECTRIMS 217, P1143.
Cholesterol en Alzheimer
feb 2019 | Dementie
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen